BOROSCI — Borosil Scientific Income Statement
0.000.00%
Last trade - 00:00- IN₹13.34bn
- IN₹12.01bn
- IN₹4.67bn
Annual income statement for Borosil Scientific, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 3,946 | 4,385 | 4,673 |
| Cost of Revenue | |||
| Gross Profit | 1,824 | 2,085 | 3,005 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 3,656 | 4,042 | 4,329 |
| Operating Profit | 290 | 343 | 344 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 316 | 404 | 428 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 235 | 267 | 346 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 236 | 268 | 346 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 236 | 268 | 346 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 2.66 | 3.03 | 4.66 |